Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study

BACKGROUND: Sodium-glucose co-transporter 2 (SGLT2) inhibitors has been shown with cardiovascular benefit in type 2 diabetes mellitus (T2DM) patients. However, its osmotic diuresis still concern physicians who may look for possible electrolyte imbalance. We therefore aimed to investigate electrocard...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Victor Chien-Chia, Chiu, Kai-Pin, Wang, Chun-Li, Hsu, Chiu-Yi, Tu, Hui-Tzu, Huang, Yu-Tung, Chang, Chih-Hsiang, Huang, Chien-Hao, Kuo, Chang-Fu, Chen, Shao-Wei, Chu, Pao-Hsien, Chang, Shang-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485575/
https://www.ncbi.nlm.nih.gov/pubmed/36148062
http://dx.doi.org/10.3389/fcvm.2022.934193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485575/
https://www.ncbi.nlm.nih.gov/pubmed/36148062
http://dx.doi.org/10.3389/fcvm.2022.934193

Ejemplares similares